| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |